Fig. 2 | Scientific Reports

Fig. 2

From: Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection

Fig. 2

Compound 24 efficiently reduced SARS-CoV-2-induced plaque formation. (A) A marked decrease in the PFU/mL was observed after treatment with compound 24 as compared to the Remdesivir at the concentration of 83 µM. (B) Representative images of Vero cells 5 dpi with SARS-CoV-2. Infected cells treated with compound 24 and RDV showed a lesser number of plaques than non-treated infected cells. The data is represented as mean ± SD.

Back to article page